Your browser doesn't support javascript.
loading
PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index.
Casazza, Andrea; Van Helleputte, Lawrence; Van Renterghem, Britt; Pokreisz, Peter; De Geest, Natalie; De Petrini, Marzia; Janssens, Tom; Pellens, Marijke; Diricx, Marjan; Riera-Domingo, Carla; Wozniak, Agnieszka; Mazzone, Massimiliano; Schöffski, Patrick; Defert, Olivier; Reyns, Geert; Kindt, Nele.
Afiliação
  • Casazza A; CoBioRes NV, Campus Gasthuisberg University of Leuven, Leuven, Belgium.
  • Van Helleputte L; CoBioRes NV, Campus Gasthuisberg University of Leuven, Leuven, Belgium.
  • Van Renterghem B; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Pokreisz P; CoBioRes NV, Campus Gasthuisberg University of Leuven, Leuven, Belgium.
  • De Geest N; CoBioRes NV, Campus Gasthuisberg University of Leuven, Leuven, Belgium.
  • De Petrini M; CoBioRes NV, Campus Gasthuisberg University of Leuven, Leuven, Belgium.
  • Janssens T; CoBioRes NV, Campus Gasthuisberg University of Leuven, Leuven, Belgium.
  • Pellens M; CoBioRes NV, Campus Gasthuisberg University of Leuven, Leuven, Belgium.
  • Diricx M; CoBioRes NV, Campus Gasthuisberg University of Leuven, Leuven, Belgium.
  • Riera-Domingo C; Laboratory of Tumor Inflammation and Angiogenesis, Vesalius Research Center, VIB, Leuven, Belgium.
  • Wozniak A; Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Mazzone M; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Schöffski P; Laboratory of Tumor Inflammation and Angiogenesis, Vesalius Research Center, VIB, Leuven, Belgium.
  • Defert O; Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Reyns G; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Kindt N; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
Mol Cancer Ther ; 21(4): 568-581, 2022 04 01.
Article em En | MEDLINE | ID: mdl-35149549
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article